bRIGHT study 1-year data card
Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.
LEARN MORE:
Related Resources
New clinical evidence and patient selection M-TEER therapy
Artifical intelligence in structural heart imaging
Anatomy for structural heart therapies
The Standard of Caring For TR
TAVI strategies for patient lifetime management
TriClip Symposium | PCR LV 2025
bRIGHT interview with X. Freixa | PCR LV 2025
TAVI webinar - key learnings in TAVI